Tag
clinical trials
- Genmab A/S reports 45.9% Rina‑S response in ovarian cancer trial
- Surrozen gains FDA IND clearance for SZN‑8141 macular edema trial
- ZYUS Life Sciences says 3 of 7 evaluable patients met pain threshold
- Wave Life Sciences plans two‑year WVE‑006 trial after FDA feedback
- Pfizer Inc details 61% EASI‑75 response in tilrekimig trial
- MediciNova misses both Phase 2 endpoints despite HDL gains
- Immunovant drops cutaneous lupus program after IMVT‑1402 trial miss
- Ionis Pharmaceuticals' Phase 3 kidney trial meets proteinuria endpoint
- Amplia signs Eli Lilly collaboration for Phase 1b/2b lung cancer trial
- Enliven Therapeutics stock climbs on upgrades, sector validation from Merck acquisition
- 60 Degrees Pharma flies after curing tick disease in small-scale study
- Galleri shows promise in large U.S. based clinical trial
- Regulus Therapeutics shares jump 135% on news of acquisition by Novartis
- Corcept Therapeutics shares double on solid Phase 3 results for ovarian cancer treatment
- Is Cardiff Oncology 15% bump due to positive clinical trials or a short squeeze?
- Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment
- Quantum BioPharma soars on clinical trial success with 'unbuzzd' hangover cure supplement
- Akero Therapeutics nearly doubles stock price on positive clinical studies
- Phio Pharmaceuticals skyrockets on skin cancer drug trial success
- Sana Biotechnology could offer relief to diabetes type 1 sufferers in the future
- Hoth Therapeutics up over 218% on dermatology breakthrough for cancer patients
- Sagimet Biosciences up 30% on strong clinical stage data
- New blood test capable of screening for over 50 cancers available in Canada
- Janux Therapeutics soars on clinical trial data for prostate cancer treatment candidate
- Neurogene patient dies in drug trial, stock surges after FDA says 'use lower dose'
- FDA gives long-awaited green light to veterans cannabis trial for PTSD
- GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most
- Rani Therapeutics enjoys 50% bump on insider buying spree
- Scholar Rock stock skyrockets on successful phase 3 trial results
- Wave Life Sciences shares pop 50% on positive clinical data for common type of muscular dystrophy
- Edgewise Therapetics shares skyrocket on positive clinical trial returns
- Prelude Therapeutics Incorporated shares drop 30% on clinical trial news
- Why are Viridian Therapeutics shares on the rise on Tuesday?
- AstraZeneca shares slide on disappointing lung cancer drug trial results
- First-ever global lung cancer vaccine trial kicks off in the UK
- Eledon Pharma completes first pig‑to‑human kidney transplant using Tegoprubart
- Alberta university kicks off major study on psilocybin for alcohol use disorder treatment
- NetraMark demonstrates efficacy of AI to help with clinical trials
- CBD relieves anxiety better than THC without paranoia, study shows
- HumanFirst connects clinical researchers to vital data using artificial intelligence-based platform
- Filament Health gets FDA approval for psilocybin studies on cancer-related anxiety and depression
- PharmAla Biotech receives guidance on new MDMA-like drug for PTSD and Autism
- FDA publishes first draft guidance document for psychedelics research
- MindBio Therapeutics receives approval for LSD study for major depression
- SciSparc conducts CBD oil clinical trial for children with autism
- Optimi Health submits clinical trial application after developing proprietary MDMA drug
- Woke Pharma and Swinburne U partner for Australia's biggest psilocybin trial
- Health Canada provides guidance for clinical trials on psychedelics
- ChitogenX completes opening phases of rotator cuff clinical trial
- Small Pharma gets approval for upcoming injectable DMT trial on humans